文献速递乳腺乳腺X线

筛查乳腺X线摄影后减少不必要活检的辅助诊断试验的性能目标:成本、获益与后果分析

Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences.
PubMed 文献 · J Am Coll Radiol · 2016-01-01

研究用决策模型从美国国家医保支付方视角、1年时间跨度、40至79岁筛查人群出发,比较在乳腺X线摄影可疑发现活检前加用辅助诊断试验与现行标准诊疗。设定辅助试验敏感度95%、特异度75%、成本1000美元时,每百万筛查女性可避免8127例不必要乳腺活检,但增加6462977美元成本并导致255例癌症诊断机会错失。作者结论为加用辅助试验可能减少许多不必要活检,同时增加总体医疗费用。

要点

  • 设定辅助试验敏感度95%、特异度75%、成本1000美元时,每百万筛查女性可避免8127例不必要乳腺活检。
  • 同一设定下每百万筛查女性增加6462977美元成本,并导致255例癌症诊断机会错失。
  • 作者认为乳腺X线摄影仍是相对廉价且有效的乳腺癌筛查与诊断方式。

核心结论

  • 在乳腺X线摄影可疑发现活检前加用辅助诊断试验可能减少许多不必要活检,但也会增加总体医疗费用,且设定参数下每百万筛查女性有255例癌症诊断机会错失。

研究设计与样本

  • 决策分析模型,从美国国家医保支付方视角、1年时间跨度,人群为代表美国筛查人群的40至79岁女性,比较辅助试验用于活检前分诊与现行标准诊疗,参数取自医学文献与专家意见,并进行敏感性分析评估参数估计不确定性的影响。

诊断标准与关键数值

  • 基础案例分析设定辅助诊断试验敏感度95%、特异度75%、成本1000美元,评估指标为增量成本、避免的良性活检数、每百万筛查女性癌症诊断机会错失数。

临床应用与阅片要点

  • 作者认为该探索性分析提示乳腺X线摄影仍是相对廉价且有效的乳腺癌筛查与诊断方式;原文未据此给出具体阅片或报告推荐。

局限性

  • 作者称该分析为探索性分析。
  • 输入参数来自医学文献与专家意见,并进行了敏感性分析以评估参数估计不确定性的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Because benign biopsies resulting from false-positive mammographic findings are a known harm of breast cancer screening, physicians and test manufacturers are searching for ways to reduce their frequency. The aim of this study was to estimate potential costs and consequences associated with using an adjunct diagnostic test for triaging women with suspicious mammographic findings before biopsy.

METHODS: A decision model was developed to compare the use of an adjunct test before biopsy to the current standard of care for suspicious mammographic findings. The decision analysis was performed from the perspective of a national health payer, with a 1-year time horizon among women representative of the US screening population aged 40 to 79 years. Three primary outcomes were assessed: (1) incremental costs, (2) number of benign biopsies avoided, and (3) number of missed opportunities for diagnosing cancer per million women screened. Input parameters were obtained from the medical literature and expert opinion. Sensitivity analyses were performed to evaluate the effects of uncertainty in parameter estimates.

RESULTS: The base-case analysis demonstrated that the use of an adjunct diagnostic test with 95% sensitivity, 75% specificity, and a cost of $1,000 would eliminate 8,127 unnecessary breast biopsies per million women screened. However, this would cost the US health care system an additional $6,462,977 and result in 255 missed opportunities for diagnosing cancer per million women screened.

CONCLUSIONS: The addition of an adjunct test for triaging women for breast biopsy after abnormal findings on screening mammography would likely eliminate many unnecessary biopsies but also increase overall health care costs. This exploratory analysis highlights the fact that mammography remains a relatively inexpensive and effective breast cancer screening and diagnostic modality.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Lee CI, Bensink ME, Berry K, et al. Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences. J Am Coll Radiol. 2016. PMID: 27814820. doi:10.1016/j.jacr.2016.09.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。